1098619-73-8 Usage
Description
Methyl 2,6-dichloro-4-iodobenzoate is a chemical compound that belongs to the class of organic compounds known as benzoic acids and derivatives. It is a derivative of benzoic acid with chloro and iodo substitutions at the 2,6 positions, featuring a methyl ester group attached to the benzene ring. Methyl 2,6-dichloro-4-iodobenzoate has potential use as a pharmaceutical intermediate or as a building block in organic synthesis, making it a valuable component in the development of various chemical and pharmaceutical products.
Uses
Used in Pharmaceutical Industry:
Methyl 2,6-dichloro-4-iodobenzoate is used as a pharmaceutical intermediate for the synthesis of various drugs and medications. Its unique structure with chloro and iodo substitutions allows for the development of new compounds with specific therapeutic properties, contributing to the advancement of pharmaceutical research and drug discovery.
Used in Organic Synthesis:
Methyl 2,6-dichloro-4-iodobenzoate serves as a building block in organic synthesis, enabling the creation of a wide range of organic compounds with diverse applications. Its versatility in chemical reactions allows chemists to modify and functionalize the molecule, leading to the synthesis of new compounds with potential applications in various industries, such as materials science, agrochemicals, and specialty chemicals.
As a Hazardous Substance:
Methyl 2,6-dichloro-4-iodobenzoate is classified as a hazardous substance, and its handling requires careful consideration of health and environmental hazards. Proper safety measures, such as the use of personal protective equipment and adherence to safety protocols, are essential to minimize potential risks associated with its use in research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1098619-73-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,8,6,1 and 9 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1098619-73:
(9*1)+(8*0)+(7*9)+(6*8)+(5*6)+(4*1)+(3*9)+(2*7)+(1*3)=198
198 % 10 = 8
So 1098619-73-8 is a valid CAS Registry Number.
1098619-73-8Relevant articles and documents
A convenient synthesis of a lymphocyte function-associated antigen-1 (LFA-1) antagonist of 'Compound 4'
Xu, Sheng,Zhou, Guo-Chun
, p. 280 - 284 (2018)
The lymphocyte function-associated antigen-1 (LFA-1) antagonist of 'Compound 4' was synthesised by a convenient route using cheap, commercially available starting materials and catalysts under mild reaction conditions and by easily handled reactions. The total yield in the preparation of 'Compound 4' was more than 38% via Sonogashira coupling of an iodide and an alkyne, reduction of the alkyne catalysed by Raney nickel and later steps involving hydrolysis of an ester, condensation of an acid and an amine and a final hydrolysis of an ester.
Preparation of fluorous Yamaguchi reagents and evaluation of their reactivity in esterification
Nishio, Yuya,Kawazu, Akari,Hirano, Shun,Matsubara, Hiroshi
, p. 720 - 725 (2016/01/15)
Fluorous Yamaguchi (FY) reagents bearing a perfluoroalkyl chain were prepared and employed in esterification reactions; the yields were similar to those obtained with the traditional Yamaguchi (TY) reagent. Fluorous benzoic acids derived from the FY reagents were separated easily after the reaction. GC analysis revealed that the initial rates of reaction with the FY reagents were higher than those with the TY reagent. The acidities of benzoic acids produced from the FY and TY reagents were predicted by DFT to be similar (1.20 and 0.96, respectively).
PYRIDINE COMPOUNDS AND USES THEREOF
-
, (2013/03/26)
The present invention is directed to pyridine compounds of Formula (I). Separate aspects of the invention are directed to pharmaceutical compositions comprising said compounds and uses of the compounds as therapeutic agents treating neurological and psych
